Media Contact:
Julia Tögel & Kerstin Mahle
E-Mail: marketing@de.gbo.com
PapilloCheck: Complete solution for detection of HPV
Greiner Bio-One GmbH is launching for the first time two variants of a specially adapted DNA Extraction Kit for its cervical (cervix uteri) cancer test system PapilloCheck. By expanding the product portfolio for the test system, the company now offers a simple and rapid complete solution for detection of human papilloma viruses (HPV).
Reliable light resistance with Light Protection Tubes
Frickenhausen, [16 September 2009] – Greiner Bio-One GmbH is expanding its range of light resistant vessels. Light Protection Tubes made of pigmented polypropylene are now also available as reaction tubes for smaller volumes up to 1.5 ml providing effective protection for photosensitive substances against harmful UV radiation.
Beauty to rival Swarovski – protein crystals in CrystalSlide
Frickenhausen, [28 July 2009] – Greiner Bio-One GmbH has developed a new platform for the production and analysis of protein crystals. CrystalSlide for counter diffusion applications enables crystals to be analysed in an X-ray source and is also suitable for applications with polarised and UV light.
-
CELLview improves microscopic vision
Frickenhausen, [13 May, 2009] – The new CELLview product family developed by Greiner Bio-One GmbH combines the convenience of a standard plastic cell culture dish with the high optical quality of a glass bottom. This new development facilitates high-resolution microscopic imaging of in-vitro cultivated cells.
Reliable identification of frozen samples
Frickenhausen, [April 24th, 2009] – Greiner Bio-One GmbH is unveiling its new Datamatrix coding service for Cryo.s freezing vials at the 15th Annual Conference and Exhibition of the Society for Biomolecular Sciences, SBS, taking place in Lille, France, from 26 to 30 April.
Sensitive, specific and fast – external validation of CytoCheck mycoplasma test kit completed
Frickenhausen – [03/17/2009] - The international congress “2009 PDA, 3rd Workshop on Mycoplasmas”, to be held in Berlin from 24 to 26 March, offers scientists from the pharmaceutical and biotechnology industries, research institutes and external contract laboratories a platform to discuss new detection methods for mycoplasmas. Greiner Bio-One GmbH will be presenting its innovative DNA chip CytoCheck, which enables 40 mycoplasmas to be detected in cell cultures at species level.
Innovative surface leading to considerably higher cell yields
Frickenhausen, October 2008 – For the first time at Biotechnica 2008, Greiner Bio-One is presenting Advanced TC™ cell culture products with an innovative polymer modification. The special surface of the new product range optimises cultivation of fastidious cells and facilitates complex experimental approaches.
Stratec, Greiner Bio-One and Maven announce development co-operation for label free system solution
Birkenfeld July 28th, 2008 - Stratec Biomedical Systems AG, Birkenfeld, Germany, Greiner Bio-One GmbH, Frickenhausen, Germany and Maven Biotechnologies, Pasadena, CA, USA signed a first agreement regarding a joint development programme.
Strategic Cooperation between European ScreeningPort GmbH and Greiner Bio-One GmbH
European ScreeningPort, the European Centre for Drug Discovery, and Greiner Bio-One GmbH,
a leading international technology partner for the diagnostic and pharmaceutical industry, are
cooperating to optimise the screening process at ESP’s facility in Hamburg, Germany.
Large working volume – low dead volume: The new 384 Deep Well Small Volume™ Microplate
Frickenhausen, 06.02.2008 – Greiner Bio-One, internationally leading technology partner for the diagnostics and pharmaceutical industry, together with Boehringer Ingelheim, Biberach, has developed the 384 Deep Well Small Volume™ Microplate for reduced volume losses during sample storage and active substance tests.
Microplates with non-binding surfaces
Frickenhausen – Greiner Bio-One announced at Medica 2007 novel microplates with
an exceptionally high protein-repellent surface. The microplates developed at the
company optimise biochemical active substance screening in that the influence of the
plate surface on the test result is minimised.
Archive